Should I buy or sell cbdMD stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" YCBD shares. View YCBD analyst ratings or view top-rated stocks .

What is cbdMD's stock price target for 2024?

1 Wall Street analysts have issued 1 year price objectives for cbdMD's shares. Their YCBD share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 226.1% from the stock's current price. View analysts price targets for YCBD or view top-rated stocks among Wall Street analysts .

Are investors shorting cbdMD?

cbdMD saw a increase in short interest in March. As of March 31st, there was short interest totaling 369,400 shares, an increase of 51.3% from the March 15th total of 244,200 shares. Based on an average daily trading volume, of 283,600 shares, the days-to-cover ratio is presently 1.3 days. Approximately 15.8% of the company's shares are sold short. View cbdMD's Short Interest .

How were cbdMD's earnings last quarter?

cbdMD, Inc. (NYSEAMERICAN:YCBD) announced its quarterly earnings data on Tuesday, February, 13th. The company reported ($0.67) EPS for the quarter. The company earned $5.38 million during the quarter. cbdMD had a negative net margin of 87.07% and a negative trailing twelve-month return on equity of 118.28%.

What ETF holds cbdMD's stock?

AXS Cannabis ETF holds 37,247 shares of YCBD stock, representing 0.35% of its portfolio.

When did cbdMD's stock split?

cbdMD's stock reverse split on Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of cbdMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other cbdMD investors own include KushCo (KSHB) , ADMA Biologics (ADMA) , Gran Tierra Energy (GTE) , Novan (NOVN) , Bionano Genomics (BNGO) , CNBX Pharmaceuticals (CNBX) , Enerplus (ERF) , Matinas BioPharma (MTNB) , Organigram (OGI) and Pennsylvania Real Estate Investment Trust (PEI) .

How do I buy shares of cbdMD?

Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEAMERICAN:YCBD

cbdMD (YCBD) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free YCBD Stock Alerts

$0.92

+0.01 (+1.10%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.86
▼
$0.95
50-Day Range: N/A
52-Week Range: $0.56
▼
$7.16

Volume: 57,944 shs
Average Volume: 274,230 shs
Market Capitalization: $2.81 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Stock Analysis Analyst Forecasts Chart Earnings Headlines Ownership Short Interest

Get cbdMD alerts:

cbdMD MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 226.1% Upside
$3.00 Price Target
Short Interest: Bearish
15.79% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.10 out of 5 stars

3.5

Analyst's Opinion

Consensus Rating
cbdMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Amount of Analyst Coverage
cbdMD has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
15.79% of the float of cbdMD has been sold short.
Short Interest Ratio / Days to Cover
cbdMD has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in cbdMD has recently increased by 51.27%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
cbdMD does not currently pay a dividend.
Dividend Growth
cbdMD does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for YCBD.

1.7

News and Social Media Coverage

News Sentiment
cbdMD has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.43 average news sentiment score of Business Services companies.
Search Interest
4 people have searched for YCBD on MarketBeat in the last 30 days.
MarketBeat Follows
3 people have added cbdMD to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, cbdMD insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.95% of the stock of cbdMD is held by insiders.
Percentage Held by Institutions
Only 7.18% of the stock of cbdMD is held by institutions.

0.6

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of cbdMD is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of cbdMD is -0.07, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
cbdMD has a P/B Ratio of 0.29. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About cbdMD Stock (NYSEAMERICAN:YCBD)

cbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.

YCBD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

YCBD Stock News Headlines

March 23, 2024 | finance.yahoo.com

cbdMD, Inc. (YCBD) Stock Historical Prices & Data - Yahoo Finance

February 13, 2024 | finance.yahoo.com

cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

February 8, 2024 | finance.yahoo.com

cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results

February 8, 2024 | finance.yahoo.com

cbdMD Welcomes Vice President of Wholesale Sales, Joe Baghadjian- Paving the Way for Future Growth

February 3, 2024 | msn.com

cbdMD Secures $1.25M Through Convertible Note Agreement

January 31, 2024 | finance.yahoo.com

cbdMD Unveils THCV+CBG Energy Softgels, Ushering in a New Era of Wellness Solutions

January 18, 2024 | finance.yahoo.com

cbdMD Launches into Sprouts Farmers Market, Bringing Premium CBD Gummies to 175 Stores Nationwide

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

January 15, 2024 | benzinga.com

cbdMD Stock (AMEX:YCBD), Guidance and Forecast

December 30, 2023 | markets.businessinsider.com

Optimistic Outlook: Buy Rating Affirmed for cbdMD Amid Growth Initiatives and Strategic Expansion

December 27, 2023 | msn.com

YCBD Stock Earnings: cbdMD Reported Results for Q4 2023

December 26, 2023 | benzinga.com

CBD Giant's Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY

December 22, 2023 | msn.com

Laidlaw cuts Cingulate to hold, cites dwindling resources

December 20, 2023 | finance.yahoo.com

cbdMD, Inc. to Host Conference Call to Discuss September 30, 2023 Fourth Quarter and Fiscal Year 2023 Results

December 14, 2023 | finance.yahoo.com

cbdMD Wins Awards in Two Categories at Prestigious Best in Biz Awards

November 15, 2023 | seekingalpha.com

YCBD.PR.A cbdMD, Inc. 8% SER A CUM PFD

October 25, 2023 | finance.yahoo.com

cbdMD Announces Cancellation of Special Meeting

October 6, 2023 | nasdaq.com

Maxim Group Initiates Coverage of cbdMD (YCBD) with Buy Recommendation

October 5, 2023 | benzinga.com

Costa Rica's FIFA-Recognized Soccer Team Turns To CBD For Injury Prevention & Healing

October 5, 2023 | finance.yahoo.com

cbdMD Announces Historic Partnership with FIFA-Affiliated Costa Rican Soccer Team

September 22, 2023 | finance.yahoo.com

cbdMD Announces Adjournment of Special Meeting

September 22, 2023 | finance.yahoo.com

Breaking Barriers: cbdMD's Research Validates Safe CBD Upper Dose

September 14, 2023 | finance.yahoo.com

Shareholders are Encouraged to Vote Well in Advance of the Proxy Deadline of 1:00 p.m. (Eastern time) on September 22, 2023

August 25, 2023 | finance.yahoo.com

Paw CBD Wins 2023 'Dog Hip & Joint Product of the Year' Pet Innovation Award

August 24, 2023 | seekingalpha.com

cbdMD suspends monthly dividend payment on series A cumulative convertible preferred stock

August 22, 2023 | finanznachrichten.de

cbdMD, Inc. Suspends Monthly Dividend Payment on Its Series A Cumulative Convertible Preferred Stock

See More Headlines

Receive YCBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/13/2024
Today: 4/17/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSEAMERICAN
Sector: Business Services
Industry: Toilet preparations
Sub-Industry: N/A
Current Symbol: NYSEAMERICAN:YCBD
CUSIP: N/A
CIK: N/A
Web: www.cbdmd.com
Phone: (704) 445-3060
Fax: N/A
Employees: 52
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $3.00
High Stock Price Target: $3.00
Low Stock Price Target: $3.00
Potential Upside/Downside: +226.1%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($12.63)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-22,940,000.00
Net Margins: -87.07%
Pretax Margin: -87.07%
Return on Equity: -118.28%
Return on Assets: -81.59%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.23
Quick Ratio: 0.64

Sales & Book Value

Annual Sales: $24.16 million
Price / Sales: 0.12
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.16 per share
Price / Book: 0.29

Miscellaneous

Outstanding Shares: 3,050,000
Free Float: 3,016,000
Market Cap: $2.81 million
Optionable: Not Optionable
Beta: 2.15

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. T. Ronan Kennedy (Age 44)
Interim CEO, Principal Executive Officer, CFO, Secretary & Treasurer
Comp: $275k
Dr. Sibyl Swift Ph.D. (Age 43)
CSO, VP of Regulatory Affairs & Director
Zeb Booker
Chief Technology Officer
Mr. John Weston
Director of Investor Relations
Mr. Lance Blundell (Age 53)
General Counsel
Robert Pettway
Director of Public Relations
Mr. Francisco Mangual (Age 45)
Senior VP of Sales
Ms. Shannon Charles
Chief Marketing Officer
Mr. David Johnson (Age 54)
Senior VP of Business Development

Key Competitors

View All Competitors

Institutional Ownership

AXS Investments LLC
Bought 27,017 shares on 2/9/2024
Ownership: 2.990%

View All Institutional Transactions

YCBD Stock Analysis - Frequently Asked Questions

Should I buy or sell cbdMD stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" YCBD shares.
View YCBD analyst ratings or view top-rated stocks.
What is cbdMD's stock price target for 2024?: 1 Wall Street analysts have issued 1 year price objectives for cbdMD's shares. Their YCBD share price targets range from $3.00 to $3.00. On average, they expect the company's stock price to reach $3.00 in the next year. This suggests a possible upside of 226.1% from the stock's current price.
View analysts price targets for YCBD or view top-rated stocks among Wall Street analysts.
Are investors shorting cbdMD?: cbdMD saw a increase in short interest in March. As of March 31st, there was short interest totaling 369,400 shares, an increase of 51.3% from the March 15th total of 244,200 shares. Based on an average daily trading volume, of 283,600 shares, the days-to-cover ratio is presently 1.3 days. Approximately 15.8% of the company's shares are sold short.
View cbdMD's Short Interest.
How were cbdMD's earnings last quarter?: cbdMD, Inc. (NYSEAMERICAN:YCBD) announced its quarterly earnings data on Tuesday, February, 13th. The company reported ($0.67) EPS for the quarter. The company earned $5.38 million during the quarter. cbdMD had a negative net margin of 87.07% and a negative trailing twelve-month return on equity of 118.28%.

What ETF holds cbdMD's stock?: AXS Cannabis ETF holds 37,247 shares of YCBD stock, representing 0.35% of its portfolio.
When did cbdMD's stock split?: cbdMD's stock reverse split on Tuesday, April 25th 2023. The 1-45 reverse split was announced on Tuesday, April 25th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 25th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.
What other stocks do shareholders of cbdMD own?: Based on aggregate information from My MarketBeat watchlists, some companies that other cbdMD investors own include KushCo (KSHB), ADMA Biologics (ADMA), Gran Tierra Energy (GTE), Novan (NOVN), Bionano Genomics (BNGO), CNBX Pharmaceuticals (CNBX), Enerplus (ERF), Matinas BioPharma (MTNB), Organigram (OGI) and Pennsylvania Real Estate Investment Trust (PEI).
How do I buy shares of cbdMD?: Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEAMERICAN:YCBD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial